Trial intelligence / Profile preview

Sinovac rabies vaccine with different PEP schedules in healthy individuals

NCT07357545Phase 3Completed

Sponsor
Sinovac Biotech Ltd.
Start
Aug 2021
Primary completion
Sep 2022
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of Rabies Vaccine (Serum-free Vero Cell) in rabies, sponsored by Sinovac Biotech Ltd.. Started Aug 2021; status: completed.

02

Drugs

Rabies Vaccine (Serum-free Vero Cell)
03

Conditions

rabies

Beyond the preview

Go deeper on NCT07357545.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07357545.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call